Clinical Trials

39 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT06081582 2023-10-13

Toripalimab in Combined With Cetuximab，Chemotherapy for Conversion Therapy of Locally Nonresectable OCSCC

33 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT04359199 2023-02-10

QUASAR

Unknown

42 enrolled

Squamous Cell Carcinoma of Head and Neck, Deglutition Disorders, Head and Neck Neoplasms, Oropharyngeal Neoplasms

NCT03552406 2021-05-06

Study of ISU104, Targeting ERBB3 in Patients With Advanced Solid Tumors

Phase 1 Unknown

33 enrolled

BreastHead & Neck

Breast Neoplasms, Head and Neck Neoplasms

NCT02054442 2021-03-12

COMMENCE

52 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT02507154 2018-08-21

NKEXPHNC

31 enrolled

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Neoplasms

NCT03051906 2017-11-22

DUCRO-HN

69 enrolled

Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT00999700 2017-09-05

INTERCEPTOR

Phase 3 Unknown

282 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT02753140 2016-04-27

Concurrent Chemoradiotherapy(CRT) in Locally Advanced(LA) SCCHN vs Cetuximab With Radiotherapy (RT) After Neoadjuvant Chemotherapy

60 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT02633176 2015-12-17

Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma

Phase 3 Unknown

120 enrolled

Nasopharyngeal Carcinoma

NCT01830556 2013-05-21

CETMET

120 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT01614938 2012-06-08

Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal Cancer

46 enrolled

Nasopharyngeal Carcinoma

NCT01472653 2011-12-13

Treatment Selection According to Skin Reaction to Cetuximab

120 enrolled

Head and Neck Neoplasms

NCT01166035 2010-07-20

TEXO

GastrointestinalHead & NeckThoracic

20 enrolled

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Colorectal Neoplasms

NCT00251381 2006-10-26

Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.

90 enrolled